NR3C2 and myocardial infarction: In heart tissue, Aldo contributes to ventricular remodelling after acute myocardial infarction, and MR antagonists exert beneficial effects, reducing sudden cardiac death and hospitalisations for heart failure when used early after myocardial infarction [27,28].